Legend Stock Analysis

LEGN
 Stock
  

USD 48.15  0.04  0.08%   

The modest gains experienced by current holders of Legend Biotech Corp may encourage institutional investors to take a closer look at the firm as it is trading at a share price of 48.15 on 551,881 in trading volume. The company directors and management have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in October. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.76. The current volatility is consistent with the ongoing market swings in October 2022 as well as with Legend Biotech Corp unsystematic, company-specific events.
Additionally, see Correlation Analysis.
  
The Legend Biotech stock analysis report makes it easy to digest most publicly released information about Legend Biotech and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Legend Stock analysis module also helps to analyze the Legend Biotech price relationship with some important fundamental indicators such as market cap and management efficiency.

Legend Stock Analysis Notes

About 32.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.59. Legend Biotech Corp had not issued any dividends in recent years. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people. To find out more about Legend Biotech Corp contact the company at 732 317 5050 or learn more at https://www.legendbiotech.com.

Legend Biotech Corp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Legend Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Legend Biotech Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the previous year's revenue of 118.59 M. Net Loss for the year was (346.4 M) with profit before overhead, payroll, taxes, and interest of 91.56 M.
Legend Biotech Corp currently holds about 791.26 M in cash with (250.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Latest headline from news.google.com: Legend Biotech Gets FDA Clearance for Small Cell Lung Cancer Trial - MarketWatch

Legend Biotech Corp Upcoming and Recent Events

Earnings reports are used by Legend Biotech to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Legend Biotech previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report17th of March 2022
Next Financial Report17th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End17th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Legend Largest EPS Surprises

Earnings surprises can significantly impact Legend Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-18
2021-03-31-0.35-0.30.0514 
2021-03-18
2020-12-31-0.28-0.220.0621 
2021-11-16
2021-09-30-0.35-0.43-0.0822 
View All Earnings Estimates

Legend Biotech SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Legend Biotech prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Legend Biotech investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Legend Biotech Corp specific information freely available to individual and institutional investors to make a timely investment decision.

Legend Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Legend Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend Biotech Corp backward and forwards among themselves. Legend Biotech's institutional investor refers to the entity that pools money to purchase Legend Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares12.1 K664 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares22.3 K811 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares15.4 K716 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares4.7 K239 K
Yong Rong Hk Asset Management LtdCommon Shares130 K6.1 M
Yong Rong Hk Asset Management LtdCommon Shares29.8 K1.5 M
Yong Rong Hk Asset Management LtdCommon Shares198.3 K5.8 M
Note, although Legend Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Legend Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 7.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Legend Biotech's market, we take the total number of its shares issued and multiply it by Legend Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Legend Profitablity

Legend Biotech's profitability indicators refer to fundamental financial ratios that showcase Legend Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, Legend Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Legend Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Legend Biotech's profitability requires more research than a typical breakdown of Legend Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (292.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (308.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -3.09.

Management Efficiency

The entity has return on total asset (ROA) of (27.65) % which means that it has lost $27.65 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (107.41) %, meaning that it created substantial loss on money invested by shareholders. Legend Biotech management efficiency ratios could be used to measure how well legend biotech corp manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 28th of November, Legend Biotech secures the Downside Deviation of 1.95, risk adjusted performance of 0.026, and Mean Deviation of 1.83. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Legend Biotech Corp, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Legend Biotech, which can be compared to its peers in the industry. Please verify Legend Biotech Corp variance, as well as the relationship between the maximum drawdown and semi variance to decide if Legend Biotech Corp is priced some-what accurately, providing market reflects its recent price of 48.15 per share. Given that Legend Biotech Corp has jensen alpha of (0.013551), we recommend you to check Legend Biotech's last-minute market performance to make sure the company can sustain itself at a future point.

Legend Biotech Corp Price Movement Analysis

The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Exponential Moving Average is calculated by weighting recent values of Legend Biotech Corp more heavily than older values.
.

Legend Biotech Predictive Daily Indicators

Legend Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Legend Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Legend Biotech Forecast Models

Legend Biotech time-series forecasting models is one of many Legend Biotech's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Legend Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Legend Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Legend Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Legend shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Legend Biotech. By using and applying Legend Stock analysis, traders can create a robust methodology for identifying Legend entry and exit points for their positions.
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people.

Current Legend Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Legend analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Legend analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
60.8Buy5Odds
Legend Biotech Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Legend analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Legend stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Legend Biotech Corp, talking to its executives and customers, or listening to Legend conference calls.
Legend Analyst Advice Details

Legend Stock Analysis Indicators

Legend Biotech Corp stock analysis indicators help investors evaluate how Legend Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Legend Biotech shares will generate the highest return on investment. By understating and applying Legend Biotech stock analysis, traders can identify Legend Biotech position entry and exit signals to maximize returns.
Quick Ratio3.73
Fifty Two Week Low30.75
Revenue Growth189.00%
Shares Short Prior Month5.52M
Average Daily Volume Last 10 Day629.47k
Average Daily Volume In Three Month716.44k
Shares Percent Shares Out4.14%
Gross Margins100.00%
Forward Price Earnings-39.11
Float Shares60.06M
Fifty Two Week High57.67
Enterprise Value To Ebitda-18.69
Fifty Day Average45.48
Two Hundred Day Average43.86
Enterprise Value To Revenue55.95
Additionally, see Correlation Analysis. Note that the Legend Biotech Corp information on this page should be used as a complementary analysis to other Legend Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Legend Stock analysis

When running Legend Biotech Corp price analysis, check to measure Legend Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend Biotech is operating at the current time. Most of Legend Biotech's value examination focuses on studying past and present price action to predict the probability of Legend Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend Biotech's price. Additionally, you may evaluate how the addition of Legend Biotech to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Legend Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
8.1 B
Quarterly Revenue Growth YOY
1.89
Return On Assets
(0.28) 
Return On Equity
(1.07) 
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.